Home Services & Solutions Hits Finding Discovery Biology In vitro Biology Enzymes/Biochemical Assays Ion Channel Cellular Assays GPCR, Transporter and NHR Radioactive Assays Cancer Cell Panel & In Vitro Oncology Assays In Vitro Assays for Diabetes and Other Metabolic Diseases High Throughput Screening High Content Platform In vivo Pharmacology & PK/PD Cardiovascular Diseases Metabolic Diseases Fibrosis: Lung, Liver, Kidney Central Nervous System & Pain Respiratory: Asthma & COPD IBS/IBD Animal Models Large Animal Disease Models Infectious Disease Antiviral Services Virology Assays Supporting Human Clinical Trials HBV Platform Safety and Early Toxicity In Vitro Safety Profiling for Medchem Support In Vitro Tox Assays for Medchem Support Early Stage Safety Assessment Oncology & Immunology Integrated Target Identification and Validation Platform Tumor Models Immuno-oncology Innovative Translational Research Platform (NHP) Biomarker Autoimmune and Inflammatory Animal Models OncoWuXi Database Discovery Services Hits Finding Structure Based Drug Discovery Protein Production X-ray Crystallography CryoEM Biophysical Assays and Screening FBDD - Fragment Screening Biopharmaceutical Assays FTE Chemistry Services Technology Platform Specialty Chemistry Integrated Discovery Academic Discovery Biology Chemistry Analysis Separation Center Center of Natural Product Impurity Isolation and Identification Physicochemical Characterization & Others Pharmaceutical Analysis ASMS Screening Therapeutic Areas Cardiovascular Diseases Metabolic Diseases Fibrosis lung, liver, kidney Central Nervous System & Pain Respiratory: Asthma & COPD Infectious Disease Oncology & Immunology Autoimmune and Inflammatory Our Brand HD Biosciences Crelux DELopen DELight OncoWuXi About Us About WuXi AppTec Discovery Services Leadership About WuXi AppTec News & Events News Upcoming Events Resource Library Webinars Newsletter Latest Sciences Literature Download Contact
IDSU Integrated Medchem Programs We offer comprehensive end-to-end solutions for creating, identifying, and supporting preclinical candidates, from discovery to development, with our integrated chemistry and biology research platform Hits Identification Target validation HTS- novel/ focused libraries DNA-Encoded Libraries High quality protein production Fragment screening and biophysical hit finding X-ray crystallography CADD (molecular docking, homology modeling, pharmacophore modeling, core hopping, virtual screening) MedChem and Synthetic Chemistry Medchem design Synthetic chemistry- special chemistry platform, unique scaffolds/ building blocks, high throughput synthesis/ purification Large scale SFC/ chiral separation. Impurity isolation and identification Project management Compound management Deliver preclinical candidates In vitro and In vivo Biology Multiple biology screening platform Infectious disease platform Specialty models including NASH Autoimmune and inflammatory diseases Electrophysiology DMPK In vitro/ In vivo ADME Preformulation Bioanalytical method development Rodents to NHPs PK PD models In vivo PK/ PD (Biomarkers) Metabolite ID Radiolabeled studies Mass Balance Discovery to IND-enabling (FDA, CFDA, EMA) Tox Non-GLP and GLP Safety pharmacology Genetic & in vitro toxicology Developmental & reproductive toxicology Ocular toxicology Toxicokinetcis & bioanalytical analysis Pathology Business Contact: North America: Declan Ryan, declan.ryan@wuxiapptec.com Europe and Israel: Dave Madge, dave_madge@wuxiapptec.com China: Marcher Xu, xu_longji@wuxiapptec.com Asia Pacific: Suk Young Cho, sycho@wuxiapptec.com